NCT07611929 Correlation Studies on Human Body Composition Based on Bioequivalence or Pharmacokinetic Trials
| NCT ID | NCT07611929 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital of Wenzhou Medical University |
| Condition | Healhty |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2024-10-05 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2024-10-05 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this observational study is to investigate the impact of body composition on the absorption, distribution, and metabolism of drugs. The primary question it seeks to answer is: Does body composition affect the absorption, distribution, and metabolism of drugs? By combining pharmacokinetic parameters and adverse drug reactions, the study will analyze differences in the metabolism of drugs under various body composition conditions. During the Phase I clinical trial, under the guidance of the researchers, subjects will use the non-invasive InBody S10 body composition analyzer to obtain body composition data, including but not limited to inorganic salts, muscle mass, lean body mass, body weight, and body fat percentage.
Eligibility Criteria
Inclusion Criteria: 1. Participants who have been successfully enrolled in the bioequivalence trials of Progesterone Sustained-release vaginal gel； 2. Have signed the informed consent form, have a full understanding of the content, process, and risks of this study, and can communicate well with the researchers. Exclusion Criteria:1: 1）Participants who may not be able to complete the study for other reasons or are deemed by the investigator to be unsuitable for participation in this study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07611929 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Healhty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07611929 currently recruiting?
Yes, NCT07611929 is actively recruiting participants. Contact the research team at liting1021@aliyun.com for enrollment information.
Where is the NCT07611929 trial being conducted?
This trial is being conducted at Wenzhou, China.
Who is sponsoring the NCT07611929 clinical trial?
NCT07611929 is sponsored by Second Affiliated Hospital of Wenzhou Medical University. The trial plans to enroll 3,000 participants.